Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
出版年份 2013 全文链接
标题
Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
作者
关键词
-
出版物
HEMATOLOGICAL ONCOLOGY
Volume 32, Issue 1, Pages 1-9
出版商
Wiley
发表日期
2013-03-20
DOI
10.1002/hon.2046
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences
- (2016) Xavier Thomas Expert Opinion on Drug Discovery
- Acute myeloid leukaemia in adults
- (2013) Felicetto Ferrara et al. LANCET
- Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia
- (2012) A. Quintas-Cardama et al. BLOOD
- Acute myeloid leukemia in the real world: why population-based registries are needed
- (2012) G. Juliusson et al. BLOOD
- The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML
- (2012) Alan K. Burnett et al. BRITISH JOURNAL OF HAEMATOLOGY
- Treatment of Unfit Patients With Acute Myeloid Leukemia: A Still Open Clinical Challenge
- (2012) Felicetto Ferrara Clinical Lymphoma Myeloma & Leukemia
- Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome
- (2012) B. Deschler et al. HAEMATOLOGICA
- Survival for older patients with acute myeloid leukemia: a population-based study
- (2012) B. Oran et al. HAEMATOLOGICA
- Acute myeloid leukemia in older adults
- (2012) Masamitsu Yanada et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia
- (2012) Krzysztof Mrózek et al. JOURNAL OF CLINICAL ONCOLOGY
- Gemtuzumab Ozogamicin: Time to Resurrect?
- (2012) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia
- (2012) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
- (2012) Stefan Faderl et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- (2012) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison
- (2012) A K Burnett et al. LEUKEMIA
- Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients
- (2011) U. Brunnberg et al. ANNALS OF ONCOLOGY
- Applicability of a "Pick a Winner" trial design to acute myeloid leukemia
- (2011) R. K. Hills et al. BLOOD
- Acute myeloid leukaemia in the elderly: a review
- (2011) Daniel A. Pollyea et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly
- (2011) Felicetto Ferrara et al. CANCER
- Azacitidine for the treatment of patients with acute myeloid leukemia
- (2011) Luca Maurillo et al. CANCER
- A Network Meta-analysis of Randomized Controlled Trials of Induction Treatments in Acute Myeloid Leukemia in the Elderly
- (2011) Dimitrios C. Ziogas et al. CLINICAL THERAPEUTICS
- Induction and postremission strategies in acute myeloid leukemia: what is new?
- (2011) Yishai Ofran et al. CURRENT OPINION IN HEMATOLOGY
- Chromatin modifying agents – the cutting edge of anticancer therapy
- (2011) Faith A.A. Kwa et al. DRUG DISCOVERY TODAY
- A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
- (2011) M. Lubbert et al. HAEMATOLOGICA
- Azacitidine has limited activity in ‘real life’ patients with MDS and AML: a single centre experience
- (2011) Murat Ozbalak et al. HEMATOLOGICAL ONCOLOGY
- Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
- (2011) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
- (2011) Guillermo Garcia-Manero et al. JOURNAL OF CLINICAL ONCOLOGY
- The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome
- (2011) A K Burnett et al. LEUKEMIA
- Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
- (2011) D A Pollyea et al. LEUKEMIA
- New Prognostic Markers in Acute Myeloid Leukemia: Perspective from the Clinic
- (2011) J. M. Foran Hematology-American Society of Hematology Education Program
- Has there been progress in the treatment of older patients with acute myeloid leukemia?
- (2010) Harry P. Erba BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study
- (2010) B. Lowenberg et al. BLOOD
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- Farnesyltransferase inhibitors: where are we now?
- (2010) Apostolia Maria Tsimberidou et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- European Development of Clofarabine as Treatment for Older Patients With Acute Myeloid Leukemia Considered Unsuitable for Intensive Chemotherapy
- (2010) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute Myeloid Leukemia or Myelodysplastic Syndrome in Randomized Controlled Clinical Trials of Cancer Chemotherapy With Granulocyte Colony-Stimulating Factor: A Systematic Review
- (2010) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study
- (2010) Cecile Pautas et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of older patients with acute myeloid leukaemia
- (2010) Felicetto Ferrara LANCET
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine
- (2010) W. Blum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
- (2009) J.-L. Harousseau et al. BLOOD
- The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial
- (2009) Alan K. Burnett et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clofarabine: emerging role in leukemias
- (2009) Keeran Sampat et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors
- (2009) Hagop M. Kantarjian et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
- (2009) Lanlan Shen et al. JOURNAL OF CLINICAL ONCOLOGY
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia
- (2009) Amanda F. Cashen et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
- (2009) Bob Löwenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- What is the role of reduced-intensity transplantation in the treatment of older patients with AML?
- (2009) S. J. Forman Hematology-American Society of Hematology Education Program
- Vulnerable and frail elderly: An approach to the management of the main tumour types
- (2008) Silvio Monfardini et al. EUROPEAN JOURNAL OF CANCER
- Clinically useful prognostic factors in acute myeloid leukemia
- (2007) Felicetto Ferrara et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started